Atlas Trials

Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)

Clinical trial NCT00958386 · COMPLETED

Trial details

NCT number
NCT00958386
Sponsor
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2009-08-01
Primary completion
2014-07-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.